Companies
AM
STOXX 600Health Care· Denmark

AMBU-B

Challenger

Ambu

$70.80

+4.50%

Open $67.85·Prev $67.75

as of 17 Apr

CHALLENGER

Power Core

Ambu's moat is the clinical and economic logic of single-use endoscopy, which eliminates reprocessing costs and cross-contamination risk.

Published18 Apr 2026
UniverseSTOXX 600
SectorHealth Care

Direction of Movement

upward

ROC 200

-33.1%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.